BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 21283540)

  • 1. CCL25/CCR9 interactions regulate large intestinal inflammation in a murine model of acute colitis.
    Wurbel MA; McIntire MG; Dwyer P; Fiebiger E
    PLoS One; 2011 Jan; 6(1):e16442. PubMed ID: 21283540
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CCL25/CCR9 interactions are not essential for colitis development but are required for innate immune cell protection from chronic experimental murine colitis.
    Wurbel MA; Le Bras S; Ibourk M; Pardo M; McIntire MG; Coco D; Geha RS; Fiebiger E; Snapper SB
    Inflamm Bowel Dis; 2014 Jul; 20(7):1165-76. PubMed ID: 24874458
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CCL25/CCR9 interactions regulate the function of iNKT cells in oxazolone-induced colitis in mice.
    Zhu S; Bing Y; Wang X; Yu Q; Wang Y; Xu S; Song L; Wang X; Xia B; Zhu Y; Zhou R
    PLoS One; 2014; 9(6):e100167. PubMed ID: 24936795
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of beta7 integrin and the chemokine/chemokine receptor pair CCL25/CCR9 in modeled TNF-dependent Crohn's disease.
    Apostolaki M; Manoloukos M; Roulis M; Wurbel MA; Müller W; Papadakis KA; Kontoyiannis DL; Malissen B; Kollias G
    Gastroenterology; 2008 Jun; 134(7):2025-35. PubMed ID: 18439426
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MLN3126, an antagonist of the chemokine receptor CCR9, ameliorates inflammation in a T cell mediated mouse colitis model.
    Igaki K; Komoike Y; Nakamura Y; Watanabe T; Yamasaki M; Fleming P; Yang L; Soler D; Fedyk E; Tsuchimori N
    Int Immunopharmacol; 2018 Jul; 60():160-169. PubMed ID: 29730559
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CCR9 signaling in dendritic cells drives the differentiation of Foxp3
    Pathak M; Padghan P; Halder N; Shilpi ; Kulkarni N; Sonar SA; Lal G
    Eur J Immunol; 2020 Mar; 50(3):404-417. PubMed ID: 31755547
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impaired CCR9/CCL25 signalling induced by inefficient dendritic cells contributes to intestinal immune imbalance in nonalcoholic steatohepatitis.
    Gao W; Wang Y; Bi J; Chen X; Li N; Wang Y; Tang H; Mao J
    Biochem Biophys Res Commun; 2021 Jan; 534():34-40. PubMed ID: 33310185
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CCR9+ plasmacytoid dendritic cells in the small intestine suppress development of intestinal inflammation in mice.
    Mizuno S; Kanai T; Mikami Y; Sujino T; Ono Y; Hayashi A; Handa T; Matsumoto A; Nakamoto N; Matsuoka K; Hisamatsu T; Takaishi H; Hibi T
    Immunol Lett; 2012 Aug; 146(1-2):64-9. PubMed ID: 22626536
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Granulocyte-macrophage colony stimulating factor blockade promotes ccr9(+) lymphocyte expansion in Nod2 deficient mice.
    Samson CM; Jurickova I; Molden E; Schreiner W; Colliver J; Bonkowski E; Han X; Trapnell BC; Denson LA
    Inflamm Bowel Dis; 2011 Dec; 17(12):2443-55. PubMed ID: 21381154
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intestinal CCL25 expression is increased in colitis and correlates with inflammatory activity.
    Trivedi PJ; Bruns T; Ward S; Mai M; Schmidt C; Hirschfield GM; Weston CJ; Adams DH
    J Autoimmun; 2016 Apr; 68():98-104. PubMed ID: 26873648
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intestinal Dendritic Cells Are Altered in Number, Maturity and Chemotactic Ability in Fulminant Hepatic Failure.
    Liu M; Wang P; Zhao M; Liu DY
    PLoS One; 2016; 11(11):e0166165. PubMed ID: 27832135
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CCR9 Antagonists in the Treatment of Ulcerative Colitis.
    Bekker P; Ebsworth K; Walters MJ; Berahovich RD; Ertl LS; Charvat TT; Punna S; Powers JP; Campbell JJ; Sullivan TJ; Jaen JC; Schall TJ
    Mediators Inflamm; 2015; 2015():628340. PubMed ID: 26457007
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CCL25/CCR9 promotes the induction and function of CD103 on intestinal intraepithelial lymphocytes.
    Ericsson A; Svensson M; Arya A; Agace WW
    Eur J Immunol; 2004 Oct; 34(10):2720-9. PubMed ID: 15368288
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased CCL25 and T Helper Cells Expressing CCR9 in the Salivary Glands of Patients With Primary Sjögren's Syndrome: Potential New Axis in Lymphoid Neogenesis.
    Blokland SLM; Hillen MR; Kruize AA; Meller S; Homey B; Smithson GM; Radstake TRDJ; van Roon JAG
    Arthritis Rheumatol; 2017 Oct; 69(10):2038-2051. PubMed ID: 28622456
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CCL25 and CCR9 is a unique pathway that potentiates pannus formation by remodeling RA macrophages into mature osteoclasts.
    Umar S; Palasiewicz K; Van Raemdonck K; Volin MV; Romay B; Ahmad I; Tetali C; Sweiss N; Amin MA; Zomorrodi RK; Shahrara S
    Eur J Immunol; 2021 Apr; 51(4):903-914. PubMed ID: 33347617
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Regulatory Function of CCR9
    Pathak M; Lal G
    Front Immunol; 2020; 11():536326. PubMed ID: 33123124
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CCR9+ T cells contribute to the resolution of the inflammatory response in a mouse model of intestinal amoebiasis.
    Rojas-López AE; Soldevila G; Meza-Pérez S; Dupont G; Ostoa-Saloma P; Wurbel MA; Ventura-Juárez J; Flores-Romo L; García-Zepeda EA
    Immunobiology; 2012 Aug; 217(8):795-807. PubMed ID: 22633147
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CCL25 mediates the localization of recently activated CD8alphabeta(+) lymphocytes to the small-intestinal mucosa.
    Svensson M; Marsal J; Ericsson A; Carramolino L; Brodén T; Márquez G; Agace WW
    J Clin Invest; 2002 Oct; 110(8):1113-21. PubMed ID: 12393847
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of CCR9 expression and CCL25/thymus-expressed chemokine responsiveness during T cell development: CD3(high)CD69+ thymocytes and gammadeltaTCR+ thymocytes preferentially respond to CCL25.
    Uehara S; Song K; Farber JM; Love PE
    J Immunol; 2002 Jan; 168(1):134-42. PubMed ID: 11751956
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mice with a selective deletion of the CC chemokine receptors 5 or 2 are protected from dextran sodium sulfate-mediated colitis: lack of CC chemokine receptor 5 expression results in a NK1.1+ lymphocyte-associated Th2-type immune response in the intestine.
    Andres PG; Beck PL; Mizoguchi E; Mizoguchi A; Bhan AK; Dawson T; Kuziel WA; Maeda N; MacDermott RP; Podolsky DK; Reinecker HC
    J Immunol; 2000 Jun; 164(12):6303-12. PubMed ID: 10843684
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.